Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

Share Price is delayed by 15 minutes
Get Live Data
43.80    0.00 (0.00%)
Bid:
42.80
Ask:
44.80
Spread: 2.00 (4.673%)
Market Cap: £68.37m
MIG3 Live PriceLast checked at - London Stock Exchange

Intraday Maven Grwth 3 Share Chart

Issue of Equity

20 Apr 2012 13:09

RNS Number : 7770B
Maven Income and Growth VCT 3 PLC
20 April 2012
 



Maven Income and Growth VCT 3 PLC

Minutes of a Meeting of Directors of the Company held by telephone on Wednesday 18 April 2012 at 4.30 p.m.

Present: Mr W G Michie (in the Chair)

Mr A Craig

Mr A Murison

Mr W R Nixon

Mr S Wood

In attendance: Maven Capital Partners UK LLP, Secretary, represented by Ms R O'Neil

1. Quorum and Declaration of Interests

The Chairman announced the presence of a quorum and that in accordance with the Articles of Association of the Company a Director could participate in a Meeting of the Board by telephone. Accordingly, the Chairman declared the Meeting duly convened and competent to proceed to business.

Each of the Directors declared his interests in the matters to be transacted at the Meeting. The Chairman noted that in terms of the Articles of Association of the Company, each of the Directors could, following his declaration of interests, be counted in the quorum and vote on the matters to be transacted at the Meeting notwithstanding his interests.

2. Purpose of the Meeting

The Chairman explained that valid applications totalling £112,339.06 had been received from investors under the Offer for Subscription (the Offer) in respect of the 2012/2013 tax year. Under the terms of the Offers Document dated 7 December 2011, these applications represented 134,182 Ordinary Shares and it was proposed that such applications should be accepted and Ordinary Shares allotted to the successful applicants.

3. Allotment of Ordinary Shares under the Offer

A schedule (the Applications Schedule) prepared by Capita Registrars detailing those applicants who had applied to subscribe for Ordinary Shares under the Offer during the period from 5 April 2012 to 18 April 2012 (the Third Closure Period) was tabled to the Meeting. It was noted that during the Third Closure Period, the Company had received applications from investors to subscribe for 134,182 Ordinary Shares under the Offer (including in respect of commission waived by financial advisers on those applications and the early investment incentive) in respect of the 2012/2013 tax year.

It was noted that cheques and/or bankers' drafts in the appropriate amounts had been received by Capita Registrars in respect of the Applications, but that not all of such cheques and/or bankers' drafts had cleared as of the time and date of the Meeting. It was further noted that the Board had a general and unconditional authority to allot equity securities under the Offer up to a nominal amount of £294,166 as if section 561(1) of the Companies Act 2006 did not apply.

 

 

Having carefully considered the Applications Schedule, it was agreed and resolved that, conditional in each case on (i) the receipt of cleared funds under each Application and (ii) the Ordinary Shares being admitted to the Official List of the UK Listing Authority and to trading on the main market of London Stock Exchange plc:

3.1.1. the Applications in the names of the persons set out in the Applications Schedule be accepted in full with immediate effect;

3.1.2. 134,182 Ordinary Shares in aggregate be allotted to the successful applicants under the Offer;

3.1.3. Capita Registrars be and is hereby authorised and instructed to prepare and despatch share and tax certificates to the successful applicants or to instruct credits to the appropriate CREST accounts of the successful applicants and to insert details of each such applicant in the Register of Allotments and the Register of Members of the Company;

3.1.4. the Secretary be authorised to make applications to the UK Listing Authority and London Stock Exchange plc for such Ordinary Shares to be admitted to the Official List and to trading on the main market of London Stock Exchange plc and to arrange for any necessary announcements to be made to a Regulatory Information Service in connection with the allotment; and

3.1.5. the Secretary was instructed to file a Form SH01 at Companies House in respect of the allotment of Ordinary Shares under the Offer.

There being no further business, the Meeting then concluded.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOELLFIFSSIIFIF
Date   Source Headline
20th May 202610:00 amRNSAdmission of Further Securities to Trading
15th May 202610:05 amRNSIssue of Equity - Dividend Investment Scheme
12th May 20263:35 pmRNSUnaudited NAV - Dividend Investment Scheme
8th May 20267:00 amRNSTransaction in Own Shares
30th Apr 20261:30 pmRNSResult of AGM
30th Apr 202610:54 amRNSAdmission of Further Securities to Trading
29th Apr 202612:28 pmRNSIssue of Equity
20th Apr 202612:23 pmRNSPublication of a Supplementary Prospectus
15th Apr 202611:19 amRNSAdmission of Further Securities to Trading
14th Apr 202611:07 amRNSIssue of Equity
8th Apr 20269:28 amRNSAdmission of Further Securities to Trading
25th Mar 202610:54 amRNSAdmission of Further Securities to Trading
24th Mar 20265:32 pmRNSAnnual Financial Report
24th Mar 202612:11 pmRNSIssue of Equity
17th Mar 20264:36 pmRNSNet Asset Value(s)
27th Feb 20265:01 pmRNSTransaction in Own Shares
27th Feb 20267:00 amRNSUnaudited NAV and Dividend Declaration
18th Feb 20264:52 pmRNSAdmission of Further Securities to Trading
17th Feb 202611:05 amRNSDirector/PDMR Shareholding
17th Feb 202611:02 amRNSDirector/PDMR Shareholding
17th Feb 202611:02 amRNSDirector/PDMR Shareholding
17th Feb 202611:00 amRNSDirector/PDMR Shareholding
17th Feb 202610:55 amRNSIssue of Equity
4th Feb 20267:00 amRNSStatement re Offer for Subscription
21st Jan 202611:03 amRNSAdmission of Further Securities to Trading
16th Jan 20269:42 amRNSIssue of Equity
14th Jan 20262:35 pmRNSUnaudited NAV - Dividend Investment Scheme
16th Dec 202510:20 amRNSIssue of Equity
4th Dec 202510:35 amRNSUnaudited NAV and Second Interim Dividend
13th Nov 20254:47 pmRNSResult of General Meeting
28th Oct 20254:24 pmRNSTransaction in Own Shares
2nd Oct 20254:42 pmRNSPublication of a Prospectus
15th Sep 20251:08 pmRNSNet Asset Value(s)
29th Aug 20257:00 amRNSIssue of Equity
20th Aug 20252:13 pmRNSStatement re Dividend Investment Scheme
23rd Jul 20254:30 pmRNSHalf-year Report
22nd Jul 20254:49 pmRNSTransaction in Own Shares
16th Jul 20257:08 amRNSStatement re Offer for Subscription
10th Jul 20254:46 pmRNSStatement re Unaudited NAV and Interim Dividend
15th May 20253:57 pmRNSTransaction in Own Shares
9th May 20259:54 amRNSDirector/PDMR Shareholding
9th May 20259:51 amRNSIssue of Equity
6th May 202511:53 amRNSIssue of Equity
2nd May 20251:11 pmRNSAudited NAV - Dividend Investment Scheme
1st May 20253:15 pmRNSResult of AGM
17th Apr 202512:56 pmRNSPublication of Suppl.Prospcts
7th Apr 20257:00 amRNSIssue of Equity - Replacement
4th Apr 20256:17 pmRNSIssue of Equity
1st Apr 202512:59 pmRNSStatement re Offers for Subscription - Closed
27th Mar 20251:11 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.